Butylphthalide (Natural) - CAS 6066-49-5
Catalog number: 6066-49-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Butylphthalide is an anti-cerebral-ischemia drug, which is first isolated from the seeds of celery, showed efficacy in animal models of stroke. It alleviates oxidative stress caused by chronic cerebral ischemia, improves cholinergic function, and inhibits amyloid beta accumulation, thereby improving cerebral neuronal injury and cognitive deficits.
Publictions citing BOC Sciences Products
  • >> More
3-n-Butylphthalide; 3-Butylphthalide
1.[Correlation Analysis Between Common Peaks of Angelica sinensis HPLC Fingerprint and Mineral Elements in Its Growing Soil].
Ding JX, Gu ZR, Wang YL, Zhang YY, Wang YP, Sun YJ. Zhong Yao Cai. 2015 Aug;38(8):1595-9.
OBJECTIVE: To investigate the correlation between common peaks of Angelica sinensis HPLC fingerprint and mineral elements in its growing soil.
2.Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
Wang CY1, Wang ZY2, Xie JW3, Wang T2, Wang X4, Xu Y5, Cai JH6. Neurobiol Aging. 2016 Feb;38:32-46. doi: 10.1016/j.neurobiolaging.2015.10.024. Epub 2015 Nov 2.
Synapse impairment in the Alzheimer's disease (AD) brain is an early event leading to cognitive dysfunction. Most oxidative stress localizes to the synapse, and synapse loss is the basis of cognitive decline in AD. Dl-3-n-butylphthalide (Dl-NBP), a small molecule compound has been shown to ameliorate oxidative stress. We evaluated the effects of a 5-month oral delivery with Dl-NBP on oxidative stress and cognitive function in APP/PS1 transgenic mice. Dl-NBP treatment reduced oxidative stress in the APP/PS1 mouse brain and alleviated learning and memory deficits. Dl-NBP supplementation meliorated synaptic plasticity, diminished soluble amyloid beta and amyloid beta oligomer in the APP/PS1 mouse brain. Dl-NBP administration caused an increase of cyclic adenosine monophosphate-response element binding protein (CREB)-binding protein (CBP)-associated Ser133-phosphorylated CREB (p-CREB) protein. Chromatin immunoprecipitation analysis revealed that Dl-NBP increased the recruitment of CBP to the promoters of best-characterized genes downstream of nuclear factor erythroid 2-related factor 2, nicotinamide adenine dinucleotide phosphate (NADPH) quinone oxidoreductase 1, and γ-glutamylcysteine synthetase modifier subunit.
3.Synthesis and biological evaluation of n-butylphthalide derivatives as anti-platelet aggregation agents.
Chen M1,2, Liu Q3, Tan M4, Wen S5, Pi R3, Lin D1,2. Nat Prod Res. 2016 Feb 15:1-4. [Epub ahead of print]
New analogues of n-butylphthalide (NBP) bearing various lengths of alkyl and different substitution at the two-position of phthalide were designed and synthesised. Preliminary evaluation and prediction of ACD LogP software indicate that the derivatives display significant improvement in water solubility than NBP does. Further biological analysis showed that NBP analogues specifically inhibit platelet aggregation induced by arachidonic acid but have no effect on that induced by adenosine 5-diphosphate. Especially compounds 1 and 3 were stronger than classical anti-platelet drug, aspirin, and equal potent with NBP, respectively. These findings provide an alternative approach to the development of NBP analogues with anti-platelet aggregation activity with good water solubility for the intervention of ischemic stroke.
4.Butylphthalide Suppresses Neuronal Cells Apoptosis and Inhibits JNK-Caspase3 Signaling Pathway After Brain Ischemia /Reperfusion in Rats.
Wen XR1,2, Tang M1,3, Qi DS1,4, Huang XJ5, Liu HZ1, Zhang F1, Wu J1, Wang YW5, Zhang XB5, Guo JQ6, Wang SL7, Liu Y1, Wang YL3, Song YJ8,9. Cell Mol Neurobiol. 2016 Mar 25. [Epub ahead of print]
Although Butylphthalide (BP) has protective effects that reduce ischemia-induced brain damage and neuronal cell death, little is known about the precise mechanisms occurring during cerebral ischemia/reperfusion (I/R). Therefore, the aim of this study was to investigate the neuroprotective mechanisms of BP against ischemic brain injury induced by cerebral I/R through inhibition of the c-Jun N-terminal kinase (JNK)-Caspase3 signaling pathway. BP in distilled non-genetically modified Soybean oil was administered intragastrically three times a day at a dosage of 15 mg/(kg day) beginning at 20 min after I/R in Sprague-Dawley rats. Immunohistochemical staining and Western blotting were performed to examine the expression of related proteins, and TUNEL-staining was used to detect the percentage of neuronal apoptosis in the hippocampal CA1 region. The results showed that BP could significantly protect neurons against cerebral I/R-induced damage.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

(CAS: 256477-09-5)

UK-371804 is a novel and selective inhibitors of urokinase plasminogen activator (uPA). UK-371804 exhibits excellent enzyme potency (Ki 10 nM) and selectivity p...

CAS 93-14-1 Guaifenesin

(CAS: 93-14-1)

Guaifenesin is thought to act as an expectorant.

CAS 446-86-6 Azathioprine

(CAS: 446-86-6)

Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation a...

CAS 113558-14-8 Ikarisoside F

Ikarisoside F
(CAS: 113558-14-8)

Ikarisoside F, a flavonol glycoside from Vancouveria hexandra, could bind to AdoHcy hydrolase.

CAS 155030-63-0 Emodepside

(CAS: 155030-63-0)

Emodepside, also known as PF 1022-221, a semisynthetic derivative of PF1022A, is efficacious against a variety of gastrointestinal nematodes and used as an anth...

CAS 7770-78-7 Arctigenin

(CAS: 7770-78-7)

Arctigenin is the aglycone of arctiin and is a lignan found in certain plants of the Asteraceae. It has shown antiviral and anticancer effects in glass. It show...


ZGN-839 is a reversible methionine aminopeptidase 2 inhibitor developed by Zafgen that has the potential to treat nonalcoholic steatohepatitis (NASH).

CAS 530141-72-1 T-5224

(CAS: 530141-72-1)

T-5224 is a selective inhibitor of c-Fos/activator protein-1. T-5224 ameliorates liver injury and improves survival through decreasing production of proinflamma...

CAS 456-59-7 Cyclandelate

(CAS: 456-59-7)

Cyclandelate is an effective inhibitor of rat hepatic acycloenzyme A: cholesterol acyltransferase (ACAT) with IC50 of 80 μM.

(CAS: 865433-00-7)

Aladorianis is a ryanodine receptor calcium release channel modulator. It is an antiarrhythmic agent. Clinical development for Chronic heart failure and Ventric...

CAS 1049743-03-4 ARM1 hydrobromide

ARM1 hydrobromide
(CAS: 1049743-03-4)

ARM1 hydrobromide is a novel Leukotriene A4 hydrolase/aminopeptidase (LTA4H) inhibitor (IC50 value of ~0.5 μM in human neutrophils, and Ki value of 2.3 μM for p...

CAS 28371-16-6 Aloin B

Aloin B
(CAS: 28371-16-6)

Aloin B is one isomer of Aloin; Aloin is a physiologically active anthraquinone present in aloe.

Carcinoembryonic Antigen CEA

Carcinoembryonic antigen (CEA), a substance found on the surface of some cells, is a tumor marker in lung cancer.

CAS 71486-22-1 Vinorelbine

(CAS: 71486-22-1)

Vinorelbine, also called Navelbine, a 5′NOR semisynthetic vinca alkaloid which arrests tumor cell growth in metaphase by binding to tubulin and preventing form...

CAS 105184-37-0 Splenopentin diacetate

Splenopentin diacetate
(CAS: 105184-37-0)

Splenopentin diacetate is a synthetic immunomodulating peptide corresponding to the region 32-34 of a splenic product called splenin (SP) and the thymic hormone...

(CAS: 1012035-06-1)

GSK894490A is a non-peptide ghrelin receptor agonist. It crosses the blood/brain barrier and elicit pro-cognitive effects in recognition and spatial learning an...

CAS 93479-97-1 Glimepiride

(CAS: 93479-97-1)

Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug.

CAS 1345407-05-7 LTX-315

(CAS: 1345407-05-7)

LTX-315, an oncolytic peptide with potent anticancer activity, kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. LTX-315 inh...

(CAS: 1404437-62-2)

ML281, a quinoxalin derivative, has been found to be a STK33 inhibitor and could have probable effect against KRAS-dependent cancers. IC50: 14 nM.

CAS 64808-48-6 Lobenzarit disodium

Lobenzarit disodium
(CAS: 64808-48-6)

Lobenzarit disodium is an immunomodulator commonly used for the treatment of arthritis.

Chemical Structure

CAS 6066-49-5 Butylphthalide (Natural)

Quick Inquiry

Verification code

Featured Items